Nonribosomal peptide synthetases
US-2015361470-A1 · Dec 17, 2015 · US
US12104180B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12104180-B2 |
| Application number | US-202017432099-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 7, 2020 |
| Priority date | Feb 10, 2020 |
| Publication date | Oct 1, 2024 |
| Grant date | Oct 1, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An enzyme with an acyl transfer function has an amino acid sequence identical to a SEQ ID NO:1, which is capable of acylation modification for macrolactins, filipins macrolides, chloramphenicol, and glycosylated piericidin A. An application of an acyltransferase of the present invention is to bind an acyl group of an acyl donor to macrolide compounds, chloramphenicol and glycosylated piericidins. The enzyme with the acyl transfer function can improve pharmacological activity of the macrolide compounds through acylation reaction of macrolactins, thereby improving bioavailability, enhancing efficacy, and reducing toxic as well as side effects, which provides a new strategy for the drug development of macrolide compounds.
Opening claim text (preview).
What is claimed is: 1. An acyltransferase, comprising: a) a protease having a sequence identical to a SEQ ID NO:1; b) a protease obtained by substituting R at position 166 or substituting E at position 128 of the protease in a), which has an acyltransferase activity of the protease in a). 2. The acyltransferase, as recited in claim 1 , wherein the protein substituting in b) is realized by substituting R at position 166 with A, G, K or Q. 3. The acyltransferase, as recited in claim 1 , wherein the protein substituting in b) is realized by substituting E at position 128 with A or Q.
containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons · CPC title
having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide heterocyclic ring, e.g. bleomycin, phleomycin · CPC title
Amides, e.g. chloramphenicol {or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes (peptides C12P21/00 or C07K)} · CPC title
Vectors or expression systems specially adapted for E. coli · CPC title
Acyltransferases (2.3) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.